Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Variant of Tumor Necrosis Factor (TNF)-? : Anti-tumor agent acting on Melanoma & Soft Tissue Sarcoma

Popular

Description

Variant of Tumor Necrosis Factor

TNF-α has been clinically proven as a tumor killing agent. M3S is a TNF-α Mutein (a variant of TNF-α) proven to have superior anti-tumor activity and safety compared to natural form. 

Mechanism of action

TNF-α Mutein (a variant of TNF-α) made from amino acids substitution of TNF-α variant which shown the highest cytotoxicity among variants.

Development status

Approved conditionally.

-       Condition : For clinical study only

-       Indication : Melanoma, sarcoma and other 3 cancers (liver cancer, breast cancer, ovary cancer)

Patent information

Patent registered in Korea (Reg. No. 123315 / 185330 / 123291), Germany (Reg. No. DE4404124), France (Reg. No. F.P.2701264), USA (USP5773582), Japan (Reg. No. JP2837344) and UK (GB2275683).

Type of business relationship sought

Out-licensing of cell line to produce M3S (Host cell : E.coli)

Full description

 

Natural TNF-α has known to have tumor killing activity and been studied clinically against cancer patients since late 1980. However, systemic administration of natural TNF-α showed severe adverse reactions. Due to the severe adverse reaction TNF-α treatment has limitation in application.

For production of effective & safe anti-tumor agent derived from TNF-α, a large number of TNF-α variant was produced and a variant with highest cytotoxicity was selected (3S). To eliminate severe toxicity, 3 amino acids of variant were substituted and a part of N-terminal amino acids were deleted (M3S).

M3S has over 10-folds lower toxicity and increased efficacy compared to natural TNF-α. It is for treatment of melanoma and soft tissue sarcoma and other cancers (liver cancer, breast cancer and ovary cancer).

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 602

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

Lokking for EU CTD Dossiers for traditional...
570 Views
Member of  Farmavita.Net from EU is looking to...
5483 Views
We are looking to acquire Azathioprine tablet...
5872 Views
I am looking for a good quality dossier with...
6618 Views
We offer for outlicensing European e-CTD...
9819 Views
Novel herbal based throat pastilles with...
1876 Views
We are looking for EU-CTD dossier...
8142 Views